Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake? - Wikidata - awgldk - TriplyDB

Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake?

Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake?

http://www.wikidata.org/entity/Q38221725

about

Shear stress blunts tubuloglomerular feedback partially mediated by primary cilia and nitric oxide at the macula densa.Renoprotection.The multiple functions of the endothelium: more than just wallpaper.

P2860

Q36339259-D80DECF1-57AC-4783-8AE5-2A11E71B6B28 Q52854341-65D777C8-9562-447E-AA32-ED8919F54BDA Q52869688-185749D5-CA15-44DA-AA1C-F71D35B231B4

P2860

Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake?

http://www.wikidata.org/entity/Q38221725

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake?

@en

type

label

Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake?

@en

prefLabel

Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake?

@en

P1433

Q38221725-AD9CEFD6-DA0F-4D7D-840B-62E5237A8989

P1476

Q38221725-F34DBC57-A8AE-447E-9FC7-88E09DFBCBA1

P2093

Q38221725-851BA382-0226-401C-AF2B-F15B832C2391

P2860

Q38221725-0B9047D1-D5B2-42AB-A38D-890466CC9CBD

Q38221725-15773B30-F9C9-4281-B219-6AF38AAA4E77

Q38221725-2D43D45D-8D89-412E-9FDA-9C7DAA2B4122

Q38221725-3BB1416D-E531-4722-B94E-E3C736740BCC

Q38221725-3FB8AE5E-4892-44CC-82B6-3345591E978B

Q38221725-5EAECC63-9982-47DD-A537-9D289A42AB60

Q38221725-6BF02630-74F7-4F8A-8970-99E0FEA6863D

Q38221725-79A7871D-8C1B-4016-BE72-8074F1F5E2D4

Q38221725-81C7940D-0B12-4410-A7C2-FDEC49F421B4

Q38221725-8247BC77-F342-4464-9484-5F2C1B7D154B

P304

Q38221725-9B699C35-4DF6-406C-9B5E-9EDB91DFCA3B

P31

Q38221725-858764E2-7DB7-443D-9D80-FC5AD4EE368D

P356

Q38221725-01BCF858-28A9-481D-9491-51544AD96E8F

P433

Q38221725-30D2CA2F-6FFC-42AD-A692-158AD2286C09

P478

Q38221725-EBFDA82E-3D55-43C5-B6B8-2B7E9E57AF39

P50

Q38221725-4A17BD39-11A8-472F-B9A5-A256C60938AF

P577

Q38221725-695FC993-6442-44BA-98FF-C75BA48E1E54

P698

Q38221725-4033B592-9962-41BD-BF5E-92AFE7F0B041

P356

P1433

Acta Physiologica

P1476

Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake?

@en

P2093

C Rosenberger

http://www.w3.org/2001/XMLSchema#string

P2860

Avosentan reduces albumin excretion in diabetics with macroalbuminuria

Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology

The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

Avosentan for overt diabetic nephropathy.

Experimental selective elevation of renal medullary blood flow in hypertensive rats: evidence against short-term hypotensive effect.

Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.

Effect of reactive oxygen species and nitric oxide in the neural control of intrarenal haemodynamics in anaesthetized normotensive rats.

Endothelin-1 and the kidney--beyond BP.

P304

1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APHA.12332

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

212

http://www.w3.org/2001/XMLSchema#string

P50

Michael Fähling

P577

2014-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24947550

http://www.w3.org/2001/XMLSchema#string